SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2026

PORTLAND, Maine, Nov. 12, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation NASDAQ:ICCC (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity, today announced its unaudited financial results for the qua…

ICCC

Related stories